Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SiBone (SIBN : NSDQ)
 
 • Company Description   
SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California.

Number of Employees: 349

 
 • Price / Volume Information   
Yesterday's Closing Price: $18.47 Daily Weekly Monthly
20 Day Moving Average: 466,347 shares
Shares Outstanding: 42.62 (millions)
Market Capitalization: $787.09 (millions)
Beta: 0.93
52 Week High: $20.05
52 Week Low: $11.70
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.28% -6.62%
12 Week 38.15% 17.99%
Year To Date 31.74% 23.40%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
471 EL CAMINO REAL SUITE 101
-
SANTA CLARA,CA 95050
USA
ph: 408-207-0700
fax: -
investors@si-bone.com http://si-bone.com
 
 • General Corporate Information   
Officers
Laura A. Francis - Chief Executive Officer
Jeffrey W. Dunn - Chairman
Anshul Maheshwari - Chief Financial Officer
John G. Freund - Director
Jeryl L. Hilleman - Director

Peer Information
SiBone (ABMD)
SiBone (DMDS)
SiBone (CPWY.)
SiBone (EQUR)
SiBone (ECIA)
SiBone (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 825704109
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 42.62
Most Recent Split Date: (:1)
Beta: 0.93
Market Capitalization: $787.09 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.17 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.62 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 27.99% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.70
Price/Cash Flow: -
Price / Sales: 4.46
EPS Growth
vs. Year Ago Period: 44.44%
vs. Previous Quarter: -36.36%
Sales Growth
vs. Year Ago Period: 24.88%
vs. Previous Quarter: -3.49%
ROE
06/30/25 - -
03/31/25 - -16.00
12/31/24 - -18.67
ROA
06/30/25 - -
03/31/25 - -11.69
12/31/24 - -13.66
Current Ratio
06/30/25 - -
03/31/25 - 8.53
12/31/24 - 7.66
Quick Ratio
06/30/25 - -
03/31/25 - 7.26
12/31/24 - 6.66
Operating Margin
06/30/25 - -
03/31/25 - -15.03
12/31/24 - -18.49
Net Margin
06/30/25 - -
03/31/25 - -15.03
12/31/24 - -18.49
Pre-Tax Margin
06/30/25 - -
03/31/25 - -15.03
12/31/24 - -18.49
Book Value
06/30/25 - -
03/31/25 - 3.93
12/31/24 - 3.98
Inventory Turnover
06/30/25 - -
03/31/25 - 1.38
12/31/24 - 1.45
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.21
12/31/24 - 0.21
Debt-to-Capital
06/30/25 - -
03/31/25 - 17.50
12/31/24 - 17.51
 

Powered by Zacks Investment Research ©